SCHEMBL30281196

SCHEMBL30281196

NC(=O)c1ncnn1CCOC(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.32
▸ BCR P11274 1/20 0.32
▸ PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23990544 0.83 PKM (0.33) ABL1BCR
SCHEMBL30281298 0.79 — —
SCHEMBL30281208 0.76 PIK3CA (0.41) PIK3CA
SCHEMBL30281273 0.75 CNR1 (0.32) —
SCHEMBL3473167 0.74 TSHR (0.33) —
SCHEMBL30281146 0.74 PIK3CA (0.33) PIK3CA
SCHEMBL23989429 0.73 BRD4 (0.33) —
SCHEMBL11559361 0.71 TLR8 (0.37) —
SCHEMBL25864888 0.71 CNR2 (0.31) —
SCHEMBL12498978 0.71 PDE4B (0.33) PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143195-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 Janssen Pharmaceutica NV (BE) 2023-03-08 — — EP disclosed
Send feedback